Literature DB >> 12109355

Green tea and prostate cancer.

Sanjay Gupta1, Hasan Mukhtar.   

Abstract

Many laboratory studies and human epidemiological data suggest that most prostate cancer deaths are attributable to lifestyle, including nutritional factors where diet plays a major role in initiation as well as subsequent progression of the disease. Under these circumstances, chemoprevention seems to be a logical and obvious strategy. Because of its long latency and high incidence, prostate cancer is an ideal disease for chemoprevention. The suitable agent(s) for prostate cancer chemoprevention should be the one(s) that has efficacy in the laboratory experiments on one hand, and also possesses proven epidemiological basis on the other hand. In this article, we address the use of green tea for prostate cancer chemoprevention. Experimental as well as the epidemiological basis for this possibility is provided.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12109355     DOI: 10.1016/s0094-0143(02)00016-2

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  2 in total

1.  (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells.

Authors:  Subhasree Roy Choudhury; Sivaprakasam Balasubramanian; Yap Ching Chew; Bingshe Han; Victor E Marquez; Richard L Eckert
Journal:  Carcinogenesis       Date:  2011-07-27       Impact factor: 4.944

Review 2.  Green tea and prostate cancer: from bench to clinic.

Authors:  Mitali Pandey; Sanjay Gupta
Journal:  Front Biosci (Elite Ed)       Date:  2009-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.